Full Text View
Tabular View
No Study Results Posted
Related Studies
DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery (AQNA-DY002)
This study has been terminated.
( Terminated due to reasons unrelated to safety )
Study NCT00596492   Information provided by Aqumen Biopharmaceuticals, N.A.
First Received: January 9, 2008   Last Updated: February 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mature Cataracts
Additional conditions recognized in this trial
Cataract
More general conditions related to this trial
Eye Diseases
Lens Diseases
Interventions listed in this trial
DYME
Sponsors listed in this trial
Aqumen Biopharmaceuticals, N.A.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services